Double Medical Technology Inc. (002901.SZ)
CNY 30.74
(-0.03%)
CNY 30.74
(-0.03%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 103.23 Million CNY | -94.71% |
| 2022 | 147.45 Million CNY | -82.06% |
| 2021 | 822 Million CNY | 15.01% |
| 2020 | 714.74 Million CNY | 25.17% |
| 2019 | 571 Million CNY | 29.54% |
| 2018 | 440.78 Million CNY | 25.61% |
| 2017 | 350.92 Million CNY | 44.43% |
| 2016 | 242.98 Million CNY | 13.59% |
| 2015 | 213.91 Million CNY | 33.96% |
| 2014 | 159.68 Million CNY | 46.64% |
| 2013 | 108.89 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 55.96 Million CNY | 192.92% |
| 2024 Q2 | 68.45 Million CNY | 22.31% |
| 2024 Q3 | 107.75 Million CNY | 81.97% |
| 2023 Q3 | 27.16 Million CNY | -35.99% |
| 2023 Q4 | -60.22 Million CNY | -321.68% |
| 2023 Q1 | 65.97 Million CNY | 155.24% |
| 2023 FY | 7.8 Million CNY | -94.71% |
| 2023 Q2 | 42.44 Million CNY | -35.66% |
| 2022 Q4 | -119.42 Million CNY | -339.42% |
| 2022 Q3 | 49.87 Million CNY | -43.81% |
| 2022 Q2 | 88.77 Million CNY | -30.76% |
| 2022 Q1 | 128.22 Million CNY | -53.98% |
| 2022 FY | 147.45 Million CNY | -82.06% |
| 2021 Q4 | 278.61 Million CNY | 65.11% |
| 2021 Q3 | 168.75 Million CNY | -22.54% |
| 2021 FY | 822 Million CNY | 15.01% |
| 2021 Q1 | 156.76 Million CNY | -24.46% |
| 2021 Q2 | 217.86 Million CNY | 38.97% |
| 2020 Q2 | 205.3 Million CNY | 93.62% |
| 2020 Q3 | 195.86 Million CNY | -4.6% |
| 2020 FY | 714.74 Million CNY | 25.17% |
| 2020 Q1 | 106.03 Million CNY | -28.99% |
| 2020 Q4 | 207.53 Million CNY | 5.96% |
| 2019 Q2 | 145.62 Million CNY | 39.18% |
| 2019 FY | 571 Million CNY | 29.54% |
| 2019 Q1 | 104.63 Million CNY | -3.71% |
| 2019 Q4 | 149.33 Million CNY | -12.88% |
| 2019 Q3 | 171.4 Million CNY | 17.7% |
| 2018 Q4 | 108.66 Million CNY | -14.15% |
| 2018 Q1 | 84.2 Million CNY | -17.35% |
| 2018 Q3 | 126.58 Million CNY | 4.33% |
| 2018 Q2 | 121.32 Million CNY | 44.09% |
| 2018 FY | 440.78 Million CNY | 25.61% |
| 2017 Q1 | 68.34 Million CNY | 25.21% |
| 2017 FY | 350.92 Million CNY | 44.43% |
| 2017 Q4 | 101.87 Million CNY | 6.93% |
| 2017 Q3 | 95.27 Million CNY | 16.98% |
| 2017 Q2 | 81.44 Million CNY | 19.17% |
| 2016 Q3 | 72.27 Million CNY | 0.0% |
| 2016 FY | 242.98 Million CNY | 13.59% |
| 2016 Q4 | 54.58 Million CNY | -24.48% |
| 2015 FY | 213.91 Million CNY | 33.96% |
| 2014 FY | 159.68 Million CNY | 46.64% |
| 2013 FY | 108.89 Million CNY | 0.0% |